nodes	percent_of_prediction	percent_of_DWPC	metapath
Practolol—ADRB1—Adrenoceptors—ADRA1D—polycystic ovary syndrome	0.0809	0.0907	CbGpPWpGaD
Practolol—ADRB1—Adrenoceptors—ADRA1B—polycystic ovary syndrome	0.0787	0.0882	CbGpPWpGaD
Practolol—ADRB1—Adrenoceptors—ADRA1A—polycystic ovary syndrome	0.0597	0.0669	CbGpPWpGaD
Practolol—ADRB1—Adrenoceptors—ADRB3—polycystic ovary syndrome	0.0574	0.0644	CbGpPWpGaD
Practolol—ADRB1—Adrenoceptors—ADRB2—polycystic ovary syndrome	0.031	0.0348	CbGpPWpGaD
Practolol—ADRB1—Monoamine GPCRs—ADRA1D—polycystic ovary syndrome	0.0286	0.0321	CbGpPWpGaD
Practolol—ADRB1—Monoamine GPCRs—ADRA1B—polycystic ovary syndrome	0.0278	0.0312	CbGpPWpGaD
Practolol—ADRB1—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.0241	0.027	CbGpPWpGaD
Practolol—ADRB1—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.0234	0.0262	CbGpPWpGaD
Practolol—Acetaminophen—SULT2A1—polycystic ovary syndrome	0.0215	0.199	CrCbGaD
Practolol—ADRB1—Monoamine GPCRs—ADRA1A—polycystic ovary syndrome	0.0211	0.0236	CbGpPWpGaD
Practolol—ADRB1—Endothelin Pathways—ADRA1A—polycystic ovary syndrome	0.0211	0.0236	CbGpPWpGaD
Practolol—ADRB1—Monoamine GPCRs—ADRB3—polycystic ovary syndrome	0.0203	0.0228	CbGpPWpGaD
Practolol—ADRB1—Amine ligand-binding receptors—ADRA1A—polycystic ovary syndrome	0.0177	0.0199	CbGpPWpGaD
Practolol—ADRB1—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.0171	0.0191	CbGpPWpGaD
Practolol—ADRB1—Monoamine GPCRs—ADRB2—polycystic ovary syndrome	0.011	0.0123	CbGpPWpGaD
Practolol—ADRB1—G alpha (s) signalling events—LHCGR—polycystic ovary syndrome	0.0109	0.0122	CbGpPWpGaD
Practolol—ADRB1—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.0102	0.0114	CbGpPWpGaD
Practolol—ADRB1—Endothelin Pathways—GNAS—polycystic ovary syndrome	0.0102	0.0114	CbGpPWpGaD
Practolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.0102	0.0944	CrCbGaD
Practolol—ADRB1—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.00922	0.0103	CbGpPWpGaD
Practolol—ADRB1—G alpha (s) signalling events—PDE3B—polycystic ovary syndrome	0.00878	0.00984	CbGpPWpGaD
Practolol—Pindolol—ADRB3—polycystic ovary syndrome	0.00875	0.0812	CrCbGaD
Practolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.00857	0.0096	CbGpPWpGaD
Practolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.00833	0.00934	CbGpPWpGaD
Practolol—ADRB1—G alpha (s) signalling events—FSHR—polycystic ovary syndrome	0.008	0.00897	CbGpPWpGaD
Practolol—ADRB1—G alpha (s) signalling events—ADRB3—polycystic ovary syndrome	0.00704	0.00789	CbGpPWpGaD
Practolol—ADRB1—G alpha (s) signalling events—LHB—polycystic ovary syndrome	0.00696	0.0078	CbGpPWpGaD
Practolol—Metipranolol—ADRB2—polycystic ovary syndrome	0.00666	0.0618	CrCbGaD
Practolol—ADRB1—G alpha (s) signalling events—SCT—polycystic ovary syndrome	0.00652	0.00731	CbGpPWpGaD
Practolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRA1A—polycystic ovary syndrome	0.00632	0.00708	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00624	0.007	CbGpPWpGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.00608	0.00682	CbGpPWpGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.00608	0.00682	CbGpPWpGaD
Practolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.00608	0.00681	CbGpPWpGaD
Practolol—Sotalol—ADRB2—polycystic ovary syndrome	0.00593	0.0551	CrCbGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00569	0.00638	CbGpPWpGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00552	0.00619	CbGpPWpGaD
Practolol—Chlorphenesin—CYP19A1—polycystic ovary syndrome	0.00538	0.0499	CrCbGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00537	0.00602	CbGpPWpGaD
Practolol—Esmolol—ADRB2—polycystic ovary syndrome	0.00529	0.0491	CrCbGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00521	0.00584	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00521	0.00584	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00487	0.00546	CbGpPWpGaD
Practolol—Propranolol—ADRB3—polycystic ovary syndrome	0.00477	0.0443	CrCbGaD
Practolol—ADRB1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00475	0.00533	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00473	0.0053	CbGpPWpGaD
Practolol—Betaxolol—ADRB2—polycystic ovary syndrome	0.00466	0.0432	CrCbGaD
Practolol—Atenolol—ADRB2—polycystic ovary syndrome	0.00461	0.0428	CrCbGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.0046	0.00516	CbGpPWpGaD
Practolol—Bisoprolol—ADRB2—polycystic ovary syndrome	0.0045	0.0417	CrCbGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00445	0.00499	CbGpPWpGaD
Practolol—ADRB1—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.00438	0.00491	CbGpPWpGaD
Practolol—Acebutolol—ADRB2—polycystic ovary syndrome	0.00426	0.0395	CrCbGaD
Practolol—Oxprenolol—ADRB2—polycystic ovary syndrome	0.00423	0.0392	CrCbGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00407	0.00456	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00397	0.00445	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00397	0.00445	CbGpPWpGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00392	0.00439	CbGpPWpGaD
Practolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.00387	0.0359	CrCbGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00381	0.00427	CbGpPWpGaD
Practolol—ADRB1—G alpha (s) signalling events—ADRB2—polycystic ovary syndrome	0.0038	0.00426	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00371	0.00416	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.0036	0.00404	CbGpPWpGaD
Practolol—Metoprolol—ADRB2—polycystic ovary syndrome	0.00359	0.0334	CrCbGaD
Practolol—ADRB1—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.00353	0.00395	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.0035	0.00393	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00349	0.00391	CbGpPWpGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00346	0.00388	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00336	0.00376	CbGpPWpGaD
Practolol—Pindolol—ADRB2—polycystic ovary syndrome	0.00333	0.0309	CrCbGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00332	0.00372	CbGpPWpGaD
Practolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00328	0.00368	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00324	0.00363	CbGpPWpGaD
Practolol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00304	0.00341	CbGpPWpGaD
Practolol—Acetaminophen—CYP1A1—polycystic ovary syndrome	0.00297	0.0276	CrCbGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00297	0.00332	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.0029	0.00325	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00269	0.00301	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00266	0.00298	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00256	0.00287	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00253	0.00283	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00247	0.00277	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00244	0.00273	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00243	0.00272	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00238	0.00267	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00238	0.00267	CbGpPWpGaD
Practolol—ADRB1—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.00237	0.00266	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00237	0.00265	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00226	0.00253	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00224	0.00251	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00224	0.00251	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00221	0.00247	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00219	0.00245	CbGpPWpGaD
Practolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00212	0.00237	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.0021	0.00235	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00204	0.00228	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00204	0.00228	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00204	0.00228	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00198	0.00222	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.0019	0.00213	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00185	0.00207	CbGpPWpGaD
Practolol—Propranolol—ADRB2—polycystic ovary syndrome	0.00181	0.0168	CrCbGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00181	0.00203	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.0018	0.00202	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.0018	0.00202	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00167	0.00187	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00165	0.00185	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00164	0.00184	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00164	0.00183	CbGpPWpGaD
Practolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.00156	0.0144	CrCbGaD
Practolol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.0015	0.00168	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00149	0.00167	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00144	0.00162	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00144	0.00162	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00143	0.0016	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.0014	0.00156	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00138	0.00155	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00136	0.00153	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00134	0.0015	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00131	0.00147	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.0013	0.00146	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.0013	0.00145	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00128	0.00143	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00128	0.00143	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00127	0.00142	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00121	0.00136	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.0012	0.00135	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.0012	0.00135	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00116	0.0013	CbGpPWpGaD
Practolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00113	0.00127	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00113	0.00126	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00109	0.00122	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00106	0.00119	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00104	0.00116	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000967	0.00108	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000943	0.00106	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00088	0.000987	CbGpPWpGaD
Practolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000862	0.000966	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000856	0.000959	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000828	0.000928	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000805	0.000902	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	0.000785	0.000879	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00078	0.000874	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000775	0.000869	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000766	0.000858	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000749	0.000839	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000725	0.000813	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000723	0.000811	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000718	0.000804	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000709	0.000794	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000685	0.000767	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000673	0.000754	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000667	0.000748	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000657	0.000736	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000623	0.000698	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000614	0.000689	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000587	0.000658	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000558	0.000626	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000549	0.000616	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000544	0.00061	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000506	0.000567	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000506	0.000567	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000487	0.000546	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000482	0.000541	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00047	0.000527	CbGpPWpGaD
Practolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000468	0.000525	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000445	0.000499	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000442	0.000496	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000441	0.000494	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000425	0.000477	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000419	0.000469	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000388	0.000435	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00037	0.000414	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000363	0.000407	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000311	0.000348	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000304	0.000341	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000271	0.000304	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000261	0.000293	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	0.00026	0.000291	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000251	0.000282	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000251	0.000282	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000239	0.000268	CbGpPWpGaD
Practolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000192	0.000215	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000164	0.000184	CbGpPWpGaD
Practolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	0.000114	0.000127	CbGpPWpGaD
